Literature DB >> 22995908

The importance of TM3-4 loop subdomains for functional reconstitution of glycine receptors by independent domains.

Bea Unterer1, Cord-Michael Becker, Carmen Villmann.   

Abstract

Truncated glycine receptors that have been found in human patients suffering from the neuromotor disorder hyperekplexia or in spontaneous mouse models resulted in non-functional ion channels. Rescue of function experiments with the lacking protein portion expressed as a separate independent domain demonstrated restoration of glycine receptor functionality in vitro. This construct harbored most of the TM3-4 loop, TM4, and the C terminus and was required for concomitant transport of the truncated α1 and the complementation domain from the endoplasmic reticulum toward the cell surface, thereby enabling complex formation of functional glycine receptors. Here, the complementation domain was stepwise truncated from its N terminus in the TM3-4 loop. Truncation of more than 49 amino acids led again to loss of functionality in the receptor complex expressed from two independent domain constructs. We identified residues 357-418 in the intracellular TM3-4 loop as being required for reconstitution of functional glycine-gated channels. All complementation constructs showed cell surface protein expression and correct orientation according to glycine receptor topology. Moreover, we demonstrated that the truncations did not result in a decreased protein-protein interaction between both glycine receptor domains. Rather, deletions of more than 49 amino acids abolished conformational changes necessary for ion channel opening. When the TM3-4 loop subdomain harboring residues 357-418 was expressed as a third independent construct together with the truncated N-terminal and C-terminal glycine receptor domains, functionality of the glycine receptor was again restored. Thus, residues 357-418 represent an important determinant in the process of conformational rearrangements following ligand binding resulting in channel opening.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995908      PMCID: PMC3493960          DOI: 10.1074/jbc.M112.376053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  A selective G betagamma-linked intracellular mechanism for modulation of a ligand-gated ion channel by ethanol.

Authors:  Gonzalo E Yevenes; Gustavo Moraga-Cid; Robert W Peoples; Günther Schmalzing; Luis G Aguayo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

2.  Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.

Authors:  Nima Melzer; Carmen Villmann; Kristina Becker; Kirsten Harvey; Robert J Harvey; Nico Vogel; Christoph J Kluck; Matthias Kneussel; Cord-Michael Becker
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

3.  An intramembrane aromatic network determines pentameric assembly of Cys-loop receptors.

Authors:  Svenja Haeger; Dmitry Kuzmin; Silvia Detro-Dassen; Niklas Lang; Michael Kilb; Victor Tsetlin; Heinrich Betz; Bodo Laube; Günther Schmalzing
Journal:  Nat Struct Mol Biol       Date:  2009-12-20       Impact factor: 15.369

4.  Novel regulatory site within the TM3-4 loop of human recombinant alpha3 glycine receptors determines channel gating and domain structure.

Authors:  Hans-Georg Breitinger; Carmen Villmann; Nima Melzer; Janine Rennert; Ulrike Breitinger; Stephan Schwarzinger; Cord-Michael Becker
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

5.  Mapping of disulfide bonds within the amino-terminal extracellular domain of the inhibitory glycine receptor.

Authors:  Nicolas Vogel; Christoph J Kluck; Nima Melzer; Stephan Schwarzinger; Ulrike Breitinger; Silke Seeber; Cord-Michael Becker
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

6.  The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression.

Authors:  Jing-Qiong Kang; Wangzhen Shen; Robert L Macdonald
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

Review 7.  Native glycine receptor subtypes and their physiological roles.

Authors:  Joseph W Lynch
Journal:  Neuropharmacology       Date:  2008-08-03       Impact factor: 5.250

8.  Functional complementation of Glra1(spd-ot), a glycine receptor subunit mutant, by independently expressed C-terminal domains.

Authors:  Carmen Villmann; Jana Oertel; Zhan-Lu Ma-Högemeier; Michael Hollmann; Rolf Sprengel; Kristina Becker; Hans-Georg Breitinger; Cord-Michael Becker
Journal:  J Neurosci       Date:  2009-02-25       Impact factor: 6.167

9.  Protein aggregation and polyasparagine-mediated cellular toxicity in Saccharomyces cerevisiae.

Authors:  Theodore W Peters; Mingxia Huang
Journal:  Prion       Date:  2007-04-26       Impact factor: 3.931

10.  The Universal Protein Resource (UniProt) 2009.

Authors: 
Journal:  Nucleic Acids Res       Date:  2008-10-04       Impact factor: 16.971

View more
  8 in total

1.  Disturbed neuronal ER-Golgi sorting of unassembled glycine receptors suggests altered subcellular processing is a cause of human hyperekplexia.

Authors:  Natascha Schaefer; Christoph J Kluck; Kerry L Price; Heike Meiselbach; Nadine Vornberger; Stephan Schwarzinger; Stephanie Hartmann; Georg Langlhofer; Solveig Schulz; Nadja Schlegel; Knut Brockmann; Bryan Lynch; Cord-Michael Becker; Sarah C R Lummis; Carmen Villmann
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

2.  Single expressed glycine receptor domains reconstitute functional ion channels without subunit-specific desensitization behavior.

Authors:  Heike Meiselbach; Nico Vogel; Georg Langlhofer; Sabine Stangl; Barbara Schleyer; Lamia'a Bahnassawy; Heinrich Sticht; Hans-Georg Breitinger; Cord-Michael Becker; Carmen Villmann
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

3.  Direct interaction of the resistance to inhibitors of cholinesterase type 3 protein with the serotonin receptor type 3A intracellular domain.

Authors:  Sita Nirupama Nishtala; Nelli Mnatsakanyan; Akash Pandhare; Chun Leung; Michaela Jansen
Journal:  J Neurochem       Date:  2016-03-11       Impact factor: 5.372

4.  New hyperekplexia mutations provide insight into glycine receptor assembly, trafficking, and activation mechanisms.

Authors:  Anna Bode; Sian-Elin Wood; Jonathan G L Mullins; Angelo Keramidas; Thomas D Cushion; Rhys H Thomas; William O Pickrell; Cheney J G Drew; Amira Masri; Elizabeth A Jones; Grace Vassallo; Alfred P Born; Fusun Alehan; Sharon Aharoni; Gerald Bannasch; Marius Bartsch; Bulent Kara; Amanda Krause; Elie G Karam; Stephanie Matta; Vivek Jain; Hanna Mandel; Michael Freilinger; Gail E Graham; Emma Hobson; Sue Chatfield; Catherine Vincent-Delorme; Jubran E Rahme; Zaid Afawi; Samuel F Berkovic; Owain W Howell; Jean-François Vanbellinghen; Mark I Rees; Seo-Kyung Chung; Joseph W Lynch
Journal:  J Biol Chem       Date:  2013-10-09       Impact factor: 5.157

Review 5.  Glycine receptor mouse mutants: model systems for human hyperekplexia.

Authors:  Natascha Schaefer; Georg Langlhofer; Christoph J Kluck; Carmen Villmann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

6.  IFN-γ-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD.

Authors:  Bea Unterer; Veit Wiesmann; Mekala Gunasekaran; Heinrich Sticht; Clara Tenkerian; Jürgen Behrens; Marina Leone; Felix B Engel; Nathalie Britzen-Laurent; Elisabeth Naschberger; Thomas Wittenberg; Michael Stürzl
Journal:  Biochem J       Date:  2018-09-25       Impact factor: 3.857

7.  Triple arginines as molecular determinants for pentameric assembly of the intracellular domain of 5-HT3A receptors.

Authors:  Akash Pandhare; Elham Pirayesh; Antonia G Stuebler; Michaela Jansen
Journal:  J Gen Physiol       Date:  2019-08-13       Impact factor: 4.086

Review 8.  The Intracellular Loop of the Glycine Receptor: It's not all about the Size.

Authors:  Georg Langlhofer; Carmen Villmann
Journal:  Front Mol Neurosci       Date:  2016-06-03       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.